The strategy is focused on treating glioblastoma ... final version yet, but we’re onto something.” Dr. Stephen Bagley, who ...
There has also been a catalogue of failed clinical trials in glioblastoma in the last few years, including the INSIGhT study of Puma Biotech's neratinib just a few days ago. Aside from ...